Stocks and Investing Stocks and Investing
Tue, December 8, 2020
Mon, December 7, 2020
Fri, December 4, 2020
Thu, December 3, 2020
Wed, December 2, 2020
Tue, December 1, 2020
Mon, November 30, 2020

Matthew Harrison Maintained (ABBV) at Buy with Increased Target to $120 on, Nov 30th, 2020


Published on 2024-10-27 14:53:41 - WOPRAI, Matthew Harrison
  Print publication without navigation


Matthew Harrison of Morgan Stanley, Maintained "AbbVie Inc." (ABBV) at Buy with Increased Target from $108 to $120 on, Nov 30th, 2020.

Matthew has made no other calls on ABBV in the last 4 months.



There are 6 other peers that have a rating on ABBV. Out of the 6 peers that are also analyzing ABBV, 0 agree with Matthew's Rating of Hold.



These are the ratings of the 6 analyists that currently disagree with Matthew


  • Gary Nachman of "BMO Capital" Initiated at Buy and Held Target at $123 on, Wednesday, November 18th, 2020
  • Geoffrey Porges of "SVB Leerink" Maintained at Buy with Decreased Target to $119 on, Monday, November 2nd, 2020
  • Andrew Baum of "Citigroup" Maintained at Strong Buy with Increased Target to $105 on, Wednesday, September 2nd, 2020
  • David Risinger of "Morgan Stanley" Maintained at Buy with Increased Target to $108 on, Thursday, August 20th, 2020
  • Randall Stanicky of "RBC Capital" Maintained at Buy with Increased Target to $127 on, Monday, August 3rd, 2020
  • Vamil Divan of "Mizuho" Maintained at Strong Buy with Increased Target to $111 on, Monday, August 3rd, 2020